What are the open and close dates of the Windlas Biotech Limited ?

Windlas Biotech Limited will be open between 2021-08-04 and 2021-08-06.

What is the allotment date for the Windlas Biotech Limited ?

Windlas Biotech Limited allotment date is 2021-08-11. For Windlas Biotech Limited allotment status check, you can visit the website of the registrar of the IPO.

Who is the registrar of Windlas Biotech Limited ?

For Windlas Biotech Limited, the IPO registrar is Link Intime India Pvt. Ltd.. You can check Windlas Biotech Limited allotment status on the website of the registrar.

Where is the Windlas Biotech Limited getting listed?

The shares are proposed to be listed on the BSE and NSE.

When will Windlas Biotech Limited shares be credited to your demat account?

The Windlas Biotech Limited shares will typically be credited to your demat account one working day before the IPO's listing date, provided your application is successfully allotted.

What is the lot size and minimum order quantity of the Windlas Biotech Limited ?

The Windlas Biotech Limited lot size is 30 and minimum order quantity is 30.

What is the price band for the Windlas Biotech Limited ?

Windlas Biotech Limited has set the price band for its IPO at 460 per equity share with a face value of 5.

Home
/
IPO

Windlas Biotech Limited

listed

₹13,440Min. investment

Bid start
4 Aug
Bid end
6 Aug
Allotment
6 Aug
Release of funds
12 Aug
Demat transfer
11 Aug
Listing
16 Aug

Windlas Biotech Limited IPO Details

Issue size

₹165Cr

IPO type

Mainboard

Price range

₹448 – ₹460

Lot size

30 shares

Price range₹448 – ₹460

IPO type

Regular

Lot size30 shares

Issue size₹165Cr

Checklist

Risk analysis

Debt to Equity ratio

Promoter holdings

Shares pledged

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Incorporated in 2009, Windlas Biotech is one of the top five pharmaceutical formulations manufacturers in India. The company provides a range of CDMO (contract development and manufacturing operations) services such as product discovery, development, licensing and commercial manufacturing of generic products. It offers CDMO services to some of the top names in the pharma industry including Pfizer, Sanofi India and Cadila Healthcare. The company derives around 85% of the revenue from this segment.

It also sells its own branded trade generic and OTC products (nutraceutical and health supplement), which contribute around 10% of the total revenue. Besides these segments, the company also garners around 5% of the revenue from exports of generic and health supplements to its primary markets like Vietnam, Myanmar, Sri Lanka, Thailand, Philippines, Cambodia, Fiji, Trinidad & Tobago and South Africa.

With the CMDO segment providing stable and steady cash flow, the company has been able to grow its topline consistently. During FY19–21, the company’s revenue has grown at a CAGR of around 18%. But, in the same period, its net profit has shrunk from ₹63.8 crore to ₹15.5 crore.

Frequently asked questions

How to invest in the Windlas Biotech Limited ?

Investors can apply for the Windlas Biotech Limited through their Demat account via the stock exchange or through their broker.

What is the issue size of Windlas Biotech Limited ?

The issue size of the Windlas Biotech Limited is 165 Cr.

What is 'pre-apply' for Windlas Biotech Limited ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Windlas Biotech Limited shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.